Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions

Oncogenic driver mutations have implications that extend beyond cancer cells themselves. Aberrant tumour cell signalling has various effects on the tumour microenvironment and anti-tumour immunity, with important consequences for therapy response and resistance. We provide an overview of how mutant...

Descripción completa

Detalles Bibliográficos
Autores principales: Watterson, Alex, Coelho, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979509/
https://www.ncbi.nlm.nih.gov/pubmed/36864508
http://dx.doi.org/10.1186/s12964-023-01063-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979509/
https://www.ncbi.nlm.nih.gov/pubmed/36864508
http://dx.doi.org/10.1186/s12964-023-01063-x

Ejemplares similares